Argus Research Maintains Buy on Nasdaq, Raises Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst Kevin Heal maintains a Buy rating on Nasdaq (NDAQ) and raises the price target from $64 to $66.
May 14, 2024 | 4:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Argus Research has maintained a Buy rating on Nasdaq (NDAQ) and increased the price target from $64 to $66, indicating a positive outlook on the stock.
The upgrade in the price target by a reputable analyst firm like Argus Research typically signals a strong confidence in the company's future performance. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100